American Century Companies Inc. Purchases 490,988 Shares of The Chemours Company $CC

American Century Companies Inc. boosted its holdings in shares of The Chemours Company (NYSE:CC) by 26.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,378,591 shares of the specialty chemicals company’s stock after acquiring an additional 490,988 shares during the period. American Century Companies Inc. owned about 1.59% of Chemours worth $37,677,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. MTM Investment Management LLC bought a new position in Chemours in the second quarter worth about $27,000. Evelyn Partners Asset Management Ltd acquired a new position in shares of Chemours during the second quarter worth $37,000. Hantz Financial Services Inc. lifted its holdings in shares of Chemours by 334.2% during the 3rd quarter. Hantz Financial Services Inc. now owns 4,329 shares of the specialty chemicals company’s stock valued at $69,000 after purchasing an additional 3,332 shares during the last quarter. Itau Unibanco Holding S.A. boosted its position in shares of Chemours by 102.3% in the 2nd quarter. Itau Unibanco Holding S.A. now owns 7,149 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 3,615 shares in the last quarter. Finally, CWM LLC boosted its position in shares of Chemours by 32.4% in the 3rd quarter. CWM LLC now owns 5,682 shares of the specialty chemicals company’s stock worth $90,000 after purchasing an additional 1,392 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on CC shares. The Goldman Sachs Group lifted their target price on shares of Chemours from $14.00 to $18.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 25th. JPMorgan Chase & Co. lifted their price objective on shares of Chemours from $13.00 to $17.00 and gave the stock a “neutral” rating in a research note on Monday, February 23rd. Mizuho boosted their price objective on shares of Chemours from $17.00 to $21.00 and gave the company an “outperform” rating in a report on Thursday. Royal Bank Of Canada reissued an “outperform” rating and issued a $18.00 price objective on shares of Chemours in a report on Friday, January 16th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chemours in a report on Wednesday, January 21st. Five analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $18.40.

Chemours Stock Performance

Shares of CC stock opened at $16.44 on Friday. The company has a current ratio of 1.78, a quick ratio of 0.85 and a debt-to-equity ratio of 16.33. The Chemours Company has a 12-month low of $9.13 and a 12-month high of $21.85. The stock has a 50 day simple moving average of $16.38 and a 200-day simple moving average of $14.74. The company has a market cap of $2.47 billion, a price-to-earnings ratio of -6.63 and a beta of 1.60.

Chemours (NYSE:CC) last released its quarterly earnings data on Thursday, February 19th. The specialty chemicals company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. Chemours had a negative net margin of 6.41% and a positive return on equity of 41.75%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the firm earned $0.09 earnings per share. The firm’s revenue was down 2.2% on a year-over-year basis. On average, equities analysts forecast that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Friday, February 27th will be issued a $0.0875 dividend. The ex-dividend date is Friday, February 27th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.1%. Chemours’s dividend payout ratio is currently -14.11%.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.